Akkermansia muciniphila is a next-generation probiotic with significant application
prospects. The role of A. muciniphila in metabolic diseases and tumor immunotherapy has …

Summary Akkermansia muciniphila (A. muciniphila), an intestinal symbiont colonizing in the
mucosal layer, is considered to be a promising candidate as probiotics. A. muciniphila is …

Inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, is a chronic
relapsing gastrointestinal inflammatory disease mediated by dysregulated immune …

The mammalian gastrointestinal tract is colonized with a majority of gut microbes, affecting
host metabolism and homeostasis. Gut microbiota plays a vital role in nutrient exchange …

Akkermansia muciniphila is a promising probiotic in the gut. This study aimed to determine
the presence and abundance of Akkermansia in patients with inflammatory bowel disease …

Akkermansia muciniphila is a Gram-negative anaerobic mucus-layer-degrading bacterium
that colonizes the intestinal mucosa of humans and rodents. Metagenomic data have shown …

The gut microbiota plays a critical role in the modulation of host metabolism and immune
response, and its impairment has been implicated in many gastrointestinal and …

Akkermansia muciniphila is potential probiotic in that its type strain ATCC BAA-835 has
beneficial effects upon obesity and diabetes. However, whether A. muciniphila can improve …

Akkermansia muciniphila, a common colonizer in the intestinal mucus layer of humans, has
gradually been considered as promising candidate for the next‐generation probiotic, given …

Ever since Akkermansia muciniphila was discovered and characterized two decades ago,
numerous studies have shown that the lack or decreased abundance of this commensal …